Tiny OncoSec Surges on Promising Phase II Melanoma Data Post author:Sam Post published:November 7, 2017 Post category:BioPharma The updated data will be presented at the 2017 Society for Immunotherapy of Cancer Annual Meeting. Source: BioSpace You Might Also Like Novartis AG Unloads Former New York Space for $18 Million, Resold for $30 Million September 14, 2017 FDA Formally Rejects Aradigm's Linhaliq, Requests a New Phase III Trial for Reconsideration January 28, 2018 MindChild Medical Inc. Announces Publication Of "Evaluation Of The Fetal QT Interval Using Non-Invasive Fetal ECG Technology" With The MERIDIAN Fetal Monitoring System April 9, 2017
FDA Formally Rejects Aradigm's Linhaliq, Requests a New Phase III Trial for Reconsideration January 28, 2018
MindChild Medical Inc. Announces Publication Of "Evaluation Of The Fetal QT Interval Using Non-Invasive Fetal ECG Technology" With The MERIDIAN Fetal Monitoring System April 9, 2017